Tag results:

flow cytometry

Reverted Exhaustion Phenotype of Circulating Lymphocytes as Immune Correlate of Anti-PD1 First-Line Treatment in Hodgkin Lymphoma

[Leukemia] Hodgkin lymphoma patients showed a decreased CD4 T-cell fraction, a higher percentage of effector-memory T cells and higher expression of activation markers at baseline.

PD-1 Inhibition in Advanced Myeloproliferative Neoplasms

[Blood Advances] Investigators conducted a multicenter, open-label, Phase II, single-arm study of pembrolizumab in patients with DIPSS intermediate 2 or greater primary, post-essential thrombocythemia or post-polycythemia vera myelofibrosis that were ineligible for or were previously treated with ruxolitinib.

SIRPĪ±-Ī±CD123 Fusion Antibodies Targeting CD123 in Conjunction with CD47 Blockade Enhance the Clearance of AML-Initiating Cells

[Journal of Hematology & Oncology] SIRPĪ±-Ī±CD123 antibodies were generated by fusing the extracellular domain of SIRPĪ± to an Ī±CD123 antibody. The binding properties of the antibodies were analyzed by flow cytometry and surface plasmon resonance.

Inhibition of Autophagy Mitigates Cell Migration and Invasion in Thyroid Cancer

[Surgery] Validated papillary, follicular, and anaplastic human thyroid cancer cell lines in culture were first assessed for autophagic capacity after bafilomycin clamping.

Live Cell Molecular Analysis of Primary Prostate Cancer Organoids Identifies Persistent Androgen Receptor Signaling

[Medical Oncology] Using orthogonal flow cytometry analysis, scientists demonstrated that primary patient-derived cancer organoid maintain distinct subsets of epithelial cells throughout culture and that these cells conserve expression of androgen receptor-related elements.

Development and Characterization of a DNA Aptamer for MLL-AF9 Expressing Acute Myeloid Leukemia Cells Using Whole Cell-SELEX

[Scientific Reports] Aptamers were selected against acute myeloid leukemia cells expressing the MLL-AF9 oncogene through systematic evolution of ligands by exponential enrichment (SELEX). Twelve rounds of SELEX, including two counter selections against fibroblast cells, were completed.

Popular